EUVIMEDEUVIMED entdecken
Open Access

Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae

Claire C Bristow, Tatum D Mortimer iD, Sheldon Morris, Yonatan H Grad iD, Olusegun O Soge, Erika Wakatake, Rushlenne Pascual, Sara McCurdy Murphy, Kyra E Fryling, Paul C Adamson, Jo-Anne Dillon iD, Nidhi R Parmar und 8 weitere

The Journal of Infectious Diseases · 12.04.2023 · 227 (7) · 917-925

DOI: 10.1093/infdis/jiad027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 03.02.2023. Verfasst von Claire C Bristow und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California San Diego, La Jolla, California, USA. Hauptthemen laut MEDLINE: Gonorrhea, Anti-Infective Agents. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, FIC NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neisseria gonorrhoeae is a major public health problem due to increasing incidence and antimicrobial resistance. Genetic markers of reduced susceptibility have been identified; the extent to which those are representative of global antimicrobial resistance is unknown. We evaluated the performance of whole-genome sequencing (WGS) used to predict susceptibility to ciprofloxacin and other antimicrobials using a global collection of N. gonorrhoeae isolates.

Methods

Susceptibility testing of common antimicrobials and the recently developed zolifodacin was performed using agar dilution to determine minimum inhibitory concentrations (MICs). We identified resistance alleles at loci known to contribute to antimicrobial resistance in N. gonorrhoeae from WGS data. We tested the ability of each locus to predict antimicrobial susceptibility.

Results

A total of 481 N. gonorrhoeae isolates, collected between 2004 and 2019 and making up 457 unique genomes, were sourced from 5 countries. All isolates with demonstrated susceptibility to ciprofloxacin (MIC ≤0.06 μg/mL) had a wild-type gyrA codon 91. Multilocus approaches were needed to predict susceptibility to other antimicrobials. All isolates were susceptible to zoliflodacin, defined by an MIC ≤0.25 μg/mL.

Conclusions

Single marker prediction can be used to inform ciprofloxacin treatment of N. gonorrhoeae infection. A combination of molecular markers may be needed to determine susceptibility for other antimicrobials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GonorrheaAnti-Infective AgentsHumansNeisseria gonorrhoeaeAnti-Bacterial AgentsCiprofloxacinMicrobial Sensitivity TestsDrug Resistance, BacterialAzithromycin

Stichwörter der Autor:innen

Neisseria gonorrhoeaeantimicrobial susceptibility testingwhole-genome sequencing

Substanzen

Anti-Bacterial AgentsCiprofloxacinAnti-Infective AgentsAzithromycin

Autor:innen und Institutionen

  • Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
  • Departments of Global Health, Allergy and Infectious Disease, Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
  • Social & Scientific Systems, a DLH Holdings Company, Silver Spring, Maryland, USA.
  • Division of Infectious Diseases at the David Geffen School of Medicine, University of California, Los Angeles, California, USA.
  • Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, Sikkim, Canada.

ORCID-Profile: Tatum D Mortimer, Yonatan H Grad, Jo-Anne Dillon

Förderung

  • NIAID NIH HHS
  • FIC NIH HHS
  • NIMH NIH HHS
  • World Health Organization
  • Division of Microbiology and Infectious Diseases
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • STAR Sexually Transmitted Infections Clinical Trials Group

Zitieren

APA

Bristow, C. C., Mortimer, T. D., Morris, S., Grad, Y. H., Soge, O. O., Wakatake, E., Pascual, R., Murphy, S. M., Fryling, K. E., Adamson, P. C., Dillon, J. A., Parmar, N. R., Le, H. H. L., Van Le, H., Ovalles Ureña, R. M., Mitchev, N., Mlisana, K., Wi, T., Dickson, S. P., & Klausner, J. D. (2023). Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae. The Journal of Infectious Diseases, 227(7), 917-925. https://doi.org/10.1093/infdis/jiad027

Vancouver

Bristow CC, Mortimer TD, Morris S, Grad YH, Soge OO, Wakatake E, et al. Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae. The Journal of Infectious Diseases. 2023;227(7):917-925. doi:10.1093/infdis/jiad027

BibTeX
@article{Bristow2023,
  author = {Bristow, Claire C and Mortimer, Tatum D and Morris, Sheldon and Grad, Yonatan H and Soge, Olusegun O and Wakatake, Erika and Pascual, Rushlenne and Murphy, Sara McCurdy and Fryling, Kyra E and Adamson, Paul C and Dillon, Jo-Anne and Parmar, Nidhi R and Le, Hai Ha Long and Van Le, Hung and Ovalles Ureña, Reyna Margarita and Mitchev, Nireshni and Mlisana, Koleka and Wi, Teodora and Dickson, Samuel P and Klausner, Jeffrey D},
  title = {Whole-Genome Sequencing to Predict Antimicrobial Susceptibility Profiles in Neisseria gonorrhoeae},
  journal = {The Journal of Infectious Diseases},
  year = {2023},
  volume = {227},
  number = {7},
  pages = {917--925},
  doi = {10.1093/infdis/jiad027}
}
Kostenlos starten →